NCT04797754 (EISA) is a clinical trial in Disabilities Physical, sponsored by University of Pittsburgh.

Who is sponsoring NCT04797754?

NCT04797754 is sponsored by University of Pittsburgh.

What condition does NCT04797754 study?

NCT04797754 studies Disabilities Physical, Sensory Disorder.

Is NCT04797754 still recruiting?

NCT04797754 is currently completed. Last updated 15 March 2021.

Last reviewed 2021-03-15 · How we verify

NCT04797754: EISA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Systematic Development and Test-Retest Reliability of EISA

Completed Last updated 15 March 2021

What this trial tests

trial in Disabilities Physical in 84 participants. Completed in 1 November 2018.

Timeline

3 November 2017

Primary endpoint
22 May 2018

1 November 2018

Quick facts

Lead sponsor	University of Pittsburgh
Status	Completed
Study type	OBSERVATIONAL
Enrollment	84
Start date	3 November 2017
Primary completion	22 May 2018
Estimated completion	1 November 2018
Sites	1 location across United States

Conditions studied

Disabilities Physical — all drugs for Disabilities Physical →
Sensory Disorder — all drugs for Sensory Disorder →

Sponsor

University of Pittsburgh

Who can join

18 and older, any sex, with Disabilities Physical or Sensory Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this proposed study, is the development and validation of EISA, a Self-report outcome measurement tool, for assessing the satisfaction of everyday functional needs, for consumers using Electronic Assistive Devices (EADs) as the primary means to complete Instrumental Activities of Daily Living (IADLs). The EISA outcome measure is proposed to be designed as a questionnaire that can be self or interview-administered to users of EADs. The development of EISA shall be modeled along the lines of development of the self-report outcome measure, Functional Mobility Assessment (FMA) (Kumar et al., 2013). The proposed tool EISA, would serve as a dynamic gage, for assessing perceived user function, related to using EADs for completing IADLs. The instrument is proposed to undergo systematic development in three phases. In phase 1, an initial pool of potential EISA items shall be generated, based on literature review data. In phase 2, content experts (clinician and EADs user) review panels, shall assess the initial pool of potential EISA items for further content validity. The objective of phase 3, would be a validation of the first iteration of EISA, by establishing reliability for test-retest administration and internal consistency, at acceptable levels, by 25-100 EADs users. Statistical analysis for test-retest reliability and internal consistency estimation shall be carried out in phase 3 of the study, using Statistical Package for the Social Sciences (SPSS) version 24 software.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Disabilities Physical

Currently open trials in the same condition.

NCT07033897 — Adapting, Implementing and Evaluating the Effectiveness of HARP for People With Disabilities · NA · recruiting

Other University of Pittsburgh trials

Trials by the same sponsor.

NCT05601206 — Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE · NA · not yet recruiting
NCT06652815 — Cognition, Metacognition, and Stigma in Patients With Suicidal Ideation · not yet recruiting
NCT06474286 — Prucalopride for Cognitive Functioning in Schizophrenia · NA · not yet recruiting
NCT06488469 — Behavioural Problems and Cognition in Children With Hypoglycemia Unawareness in Type-1 Diabetes Mellitus · NA · not yet recruiting
NCT06652802 — Effectiveness of Nurse-Conducted Brief Intervention (NCBI) Supplemented With Mobile for Preventing Alcohol Use Disorders · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04797754 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pittsburgh
Last refreshed: 15 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04797754.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing